Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

[High-risk clinically localised prostate cancer].

F Rozet1, J-N Cornu, O Cussenot

  • 1Institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France, Hôpital Tenon, 4, rue de Chine, 75020 Paris, France.

Bulletin Du Cancer
|January 12, 2011
PubMed
Summary

Identifying high-risk prostate cancer is crucial for effective treatment. Advances in molecular biology and biomarkers promise more accurate stratification and personalized therapies for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trichophyton mentagrophytes ITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

[Informed consent in radiotherapy care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).

Journal de mycologie medicale·2024
Same author

[Antimicrobial peptides: A new alternative for the treatment of aspergillosis].

Revue des maladies respiratoires·2024
Same author

[Early detection of prostate cancer: Towards a new paradigm?]

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Withdrawal notice to "Changes in the fungal nomenclature: why and how to manage?" [J Mycol Med 33 (2023) 101387].

Journal de mycologie medicale·2023

Area of Science:

  • Oncology
  • Molecular Biology
  • Medical Imaging

Context:

  • Localized prostate tumors exhibit diverse progression profiles.
  • Classical risk stratification for high-risk prostate cancer lacks consistent accuracy.
  • Emerging imaging techniques like MRI and PET-scan improve metastasis detection.

Purpose:

  • To review current methods for diagnosing and stratifying high-risk localized prostate cancer.
  • To explore the potential of molecular biology and biomarkers for improved risk assessment.
  • To discuss the implications for individualized treatment strategies.

Summary:

  • High-risk localized prostate cancer requires precise stratification for optimal outcomes.
  • Current diagnostic tools include clinical data, PSA levels, histopathology, MRI, PET-scan, and bone scans.

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Related Experiment Videos

Last Updated: Jun 5, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

  • Molecular biomarkers and genetic variations are under development for more accurate disease definition.
  • Optimal treatment often involves androgen deprivation and radiation therapy, with surgery as an option.

    • Impact:

    • Improved accuracy in identifying high-risk prostate cancer patients.
    • Potential for developing targeted therapies based on molecular profiles.
    • Facilitation of individualized treatment plans for better management and outcomes.